Showing results (1251-1260 of 1,263) with videos related to
Sort By:
Pageof 127
JCI Insight|May 22, 2026
Distinct immune landscapes characterize highly versus minimally invasive brain metastasesSarah M Maritan, Elham Karimi, Matthew Dankner, et al.Journal of Clinical Medicine|August 29, 2024
Clinical Impact of Self-Recognition of Recurrent Acute Myocardial Infarction: From KRMI-RCCKyehwan Kim, Moojun Kim, Chang-Ok Seo, et al.Journal of Clinical Medicine|July 27, 2022
Non-Renal Risk Factors for Chronic Kidney Disease in Liver Recipients with Functionally Intact Kidneys at 1 MonthDeok-Gie Kim, Shin Hwang, Jong Man Kim, et al.Nature Communications|February 11, 2025
Human and mouse proteomics reveals the shared pathways in Alzheimer's disease and delayed protein turnover in the amyloidomeJay M Yarbro, Xian Han, Abhijit Dasgupta, et al.Biorxiv : the Preprint Server for Biology|November 1, 2024
Human-mouse proteomics reveals the shared pathways in Alzheimer's disease and delayed protein turnover in the amyloidomeJay M Yarbro, Xian Han, Abhijit Dasgupta, et al.The Korean Journal of Internal Medicine|January 29, 2019
Simplified disease activity changes in real-world practice: a nationwide observational study of seropositive rheumatoid arthritis patients with moderate-to-high disease activityKichul Shin, Sung Soo Kim, Sang-Heon Lee, et al.Transplantation|February 6, 2023
Physical Performance Decline During the Early Posttransplantation Period Affects Survival After Living Donor Liver TransplantationDeok-Gie Kim, Shin Hwang, Kwang-Woong Lee, et al.Cell Host & Microbe|June 3, 2023
Secreted Akkermansia muciniphila threonyl-tRNA synthetase functions to monitor and modulate immune homeostasisSu-Man Kim, Shinhye Park, Seung-Ho Hwang, et al.Journal of Hepatology|January 29, 2020
Functions of human liver CD69+CD103-CD8+ T cells depend on HIF-2α activity in healthy and pathologic liversJong Hoon Kim, Ji Won Han, Young Joon Choi, et al.International Journal of Oncology|October 4, 2007
mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review)Irina V Lebedeva, Luni Emdad, Zao-Zhong Su, et al.Pageof 127